| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/05/2006 | EP1313762B1 Suppressor gene |
| 07/05/2006 | EP1274853B1 Materials and methods relating to immune responses to fusion proteins |
| 07/05/2006 | EP1214344B1 Dipeptidyl peptidases |
| 07/05/2006 | EP1161250B9 Immunostimulant bacterial membrane fractions in cancer treatment |
| 07/05/2006 | EP1141318B1 P450 / acetaminophen gdept for cancer treatment |
| 07/05/2006 | EP1139755B9 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 07/05/2006 | EP1133522B1 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 07/05/2006 | EP1105485B1 Human il-1 epsilon dna and polypeptides |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |
| 07/05/2006 | EP1067958B1 Treatment of cardiac hypertrophy |
| 07/05/2006 | EP1028727B1 Skin penetration enhancing components |
| 07/05/2006 | EP1015489B1 Dendritic cell receptor |
| 07/05/2006 | EP0879289B1 Human dnase resistant to actin inhibition |
| 07/05/2006 | EP0778889B1 Recombinant adenovirus comprising a chimeric penton base protein |
| 07/05/2006 | EP0733109B9 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/05/2006 | EP0721506B1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/05/2006 | EP0695360B1 Defective recombinant adenoviruses for gene therapy of tumours |
| 07/05/2006 | CN2792500Y Oral insulin corpuscle |
| 07/05/2006 | CN1798841A Complement inhibitors from ticks |
| 07/05/2006 | CN1798840A NOGO receptor binding protein. |
| 07/05/2006 | CN1798838A Inhibitor proteins of a protease and use thereof |
| 07/05/2006 | CN1798837A Thioredoxin modification |
| 07/05/2006 | CN1798769A Antibodies to masp-2 |
| 07/05/2006 | CN1798764A Peptide inhibitors of toxins derived from ll-37 |
| 07/05/2006 | CN1798740A Nitrogen-containing heteroaryl derivatives |
| 07/05/2006 | CN1798578A Medicinal compositions for improving oral absorption |
| 07/05/2006 | CN1798573A Albumin solution and method for the production thereof |
| 07/05/2006 | CN1798572A Interferon beta in severe acute respiratory syndrome (SARS) |
| 07/05/2006 | CN1798571A Pam的用途 Pam uses |
| 07/05/2006 | CN1798570A Anti-fungal compounds and methods of use |
| 07/05/2006 | CN1798569A Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 07/05/2006 | CN1798502A Method for the treatment of malignancies |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1796414A New alpha - conantokins, coded polynucleotide and application |
| 07/05/2006 | CN1796413A New T - ultra family conantokins, coded polynucleotide and application |
| 07/05/2006 | CN1796412A New 0 - ultra family conantokins, coded polynucleotide and application |
| 07/05/2006 | CN1796410A Function and application of MAAT1p15 antigen correlated to melanoma |
| 07/05/2006 | CN1796403A Polypeptide and bacterin in use for preventing and curing infection of polytype human being papilomavirus |
| 07/05/2006 | CN1795940A Sustained delivery of an active agent using an implantable system |
| 07/05/2006 | CN1795928A Correlation factor of blastocyst nidation and application |
| 07/05/2006 | CN1795924A Application and development of enhancement factor of liver regeneration as immunosuppressant |
| 07/05/2006 | CN1795922A Agent promoting the formation of skin basement membrane, agents promoting the formation of artificial skin and process for producing artificial skin |
| 07/05/2006 | CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/05/2006 | CN1262665C Code-optimized papilloma virus sequences |
| 07/05/2006 | CN1262658C Recombined expression vector of restraining multiplication of leukemia cell |
| 07/05/2006 | CN1262657C Method for producing human leukemia inhibitory factor using transgenic plant |
| 07/05/2006 | CN1262650C Tissue cement proteins from rhipicephalus appendiculatus |
| 07/05/2006 | CN1262566C Low oxygen affinity mutant hemoglobins |
| 07/05/2006 | CN1262564C Extracting method for pork liver metal sulfur protein |
| 07/05/2006 | CN1262563C Neutral and variable sites of cytomembrane protein M2 of influenza virus and their use |
| 07/05/2006 | CN1262562C HLA-A2 restraint tumor antigen peptide originating in SART-1 |
| 07/05/2006 | CN1262561C Synthetic poly peptide disturbing intracelluler signaling |
| 07/05/2006 | CN1262311C Medicinal composition for target direction transport curing cancer and its usage |
| 07/05/2006 | CN1262308C Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/05/2006 | CN1262307C Health food for diabetes patients |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071318 Comprises nucleotide sequences coding muscle ring finger protein (MURF) for use in identifying modulators which can be used to diagnose and treat cardiomyopathies |
| 07/04/2006 | US7071317 Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| 07/04/2006 | US7071316 Human Akt-3 |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071306 AMPA-binding human GluR4 receptors |
| 07/04/2006 | US7071302 Isolated protein, and amino acid sequence thereof from caenorhabditis elegans genes ced-3 and ced-4 |
| 07/04/2006 | US7071301 Supplying vector; amino acid sequence for binding virus; modifying sequence for binding second virus; genetic engineered polypeptide |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071299 For therapy of conditions characterized by inappropriate complement activation; for therapy of adult respiratory distress syndrome, ischemia-reperfusion injury, hyperacute rejection (transplantation), sepsis, cardiopulmonary bypass |
| 07/04/2006 | US7071297 Tolerogenic peptides from myelin basic protein |
| 07/04/2006 | US7071296 vaccines against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/04/2006 | US7071294 Tumor antigen protein art-1 and tumor antigen peptide thereof |
| 07/04/2006 | US7071293 Protein; biological antigrowth agent; bactericides |
| 07/04/2006 | US7071233 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex. |
| 07/04/2006 | US7071214 Compounds and compositions for delivering active agents |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7071169 Pyrane derivatives as both ACE-and NEP-inhibitors |
| 07/04/2006 | US7071168 To inhibit tumor growth in an animal; to induce apoptosis |
| 07/04/2006 | US7071167 Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines |
| 07/04/2006 | US7071166 Healing promoters for skin wounds such as rupture, abrasion, surgical incision, skin ulcer and burn. Coexistence of Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu- Met-NH2 or Phe-Gly-Leu-Met-NH2 with insulin-like growth factor-I as |
| 07/04/2006 | US7071165 LHRH antagonist peptides |
| 07/04/2006 | US7071164 Matrix metalloproteinases inhibitor peptides having sequences related to cleavage regions of the proenzyme forms of matrix |
| 07/04/2006 | US7071163 Compounds for targeting hepatocytes in vivo |
| 07/04/2006 | US7071162 Combined use of cementum attachment protein and cyclosporin a for improved attachment of dental and orthopedic implants |
| 07/04/2006 | US7071161 Variants of corticotropin releasing hormone receptor Type 1 and uses thereof |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7071159 Solubility forms; skin disorders, rheumatic disorders, antidiabetic agents |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7071004 Isolated nucleic acids; uisng gene expression as indicator of cancer; insertion gene in transgenic animals |
| 07/04/2006 | US7070994 genetic engineered retrovirus; from transgenic animals; drug transport |
| 07/04/2006 | US7070991 Cells expressing a CD4-IgG2 chimeric heterotetramer |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070973 Butyrylcholinesterase variants and methods of use |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070959 Prevent blood leakage or vacular system permeability; isolated nucleic acid; fusion protein containing endothelial growth factor and immunoglobulins |
| 07/04/2006 | US7070957 STARS—a muscle-specific actin-binding protein |
| 07/04/2006 | US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 07/04/2006 | US7070953 foods, feeds, cosmetics; fish extarct; agreegable taste, flavor, odor; incubating aqueous slurry; extraction |
| 07/04/2006 | US7070942 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 07/04/2006 | US7070940 Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein |
| 07/04/2006 | US7070931 Controlling gene expression; calibration |